What is the prognosis of patients that are diagnosed with BIA-ALCL?
- The disease course is commonly indolent and the majority of patients may be adequately treated with complete capsulectomy and implant removal.
- Even if appropriately treated, however, aggressive variants have been reported which include lymph node metastases and death.
How are patients followed for surveillance of BIA-ALCL?
- Confirmed cases of BIA-ALCL that have been adequately treated are followed with serial PET/CT scans and physical examination every 6 months for approximately 2-4 years.
- Breast Implants: Lymphoma / Blood Cancer Cases Overview
- Breast Implants and Lymphoma: Summary of Information
- Breast Implants and Lymphoma: The Disease
- Breast Implants and Lymphoma: FDA Information
- Breast Implants and Lymphoma: Resources
- Breast Implants and Lymphoma: Frequently Asked Questions